Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
measured Rank Hugo Gene description final expected
Results: HTML CSV LaTeX
Showing element 1 to 50 of 3206 in total

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
measured\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
final\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
expected\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.000173011\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3206\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.000219976\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.7865\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\parbox{\wcA}{\vspace{3pt}\noindent
0.000178236\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3204\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
ATLASTIN; GUANYLATE-BINDING PROTEIN 3. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.000219977\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.81025\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.000571223\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3205\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
C1orf166\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.000219976\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.59675\vspace{3pt}}\\\cline{1-3}\cline{5-6}
\parbox{\wcA}{\vspace{3pt}\noindent
0.00386024\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3199\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
CHMP2B\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
0.036862138\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.104721\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0100954\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3198\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
CHMP2A\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
PUTATIVE BREAST ADENOCARCINOMA MARKER (32KD). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.036862149\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.273869\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0131531\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2631\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
CHRNA6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"NEURONAL ACETYLCHOLINE RECEPTOR PROTEIN, ALPHA-6 CHAIN PRECURSOR. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.209999026\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.0626341\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0132921\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2635\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
CHRNA3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"NEURONAL ACETYLCHOLINE RECEPTOR PROTEIN, ALPHA-3 CHAIN PRECURSOR. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.20999872\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.0632961\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0139025\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2163\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
PLTP\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
PHOSPHOLIPID TRANSFER PROTEIN PRECURSOR (LIPID TRANSFER PROTEIN II). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.227243751\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.0611788\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0139875\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1813\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
CPB1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
CARBOXYPEPTIDASE B PRECURSOR (EC 3.4.17.2) (PANCREAS-SPECIFIC PROTEIN) (PASP). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.234429994\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.059666\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0141571\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2157\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
BPIL2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.227245148\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.0622988\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0142351\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2630\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
CHRNA2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"NEURONAL ACETYLCHOLINE RECEPTOR PROTEIN, ALPHA-2 CHAIN PRECURSOR. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.209999041\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.0677865\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0142939\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3192\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
STAMBPL1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ASSOCIATED MOLECULE WITH THE SH3 DOMAIN OF STAM (AMSH) LIKE PROTEIN. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.03686237\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.387764\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0145774\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2932\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
RGS19\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
REGULATOR OF G-PROTEIN SIGNALING 19 (RGS19) (G-ALPHA INTERACTING PROTEIN) (GAIP PROTEIN). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.158415218\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.0920202\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0147736\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2930\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
RGS17\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
REGULATOR OF G-PROTEIN SIGNALING 17 (RGS17). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.158415417\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.0932586\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0148857\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2929\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
RBM15\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
PUTATIVE RNA-BINDING PROTEIN 15 (RNA BINDING MOTIF PROTEIN 15) (ONE-TWENTY TWO PROTEIN). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.158415473\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.0939662\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.015194\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2927\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
LBX1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
TRANSCRIPTION FACTOR LBX1. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.158415883\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.0959121\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0153184\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1619\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
OPHN1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
OLIGOPHRENIN 1. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.239597084\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.063934\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0157159\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2160\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
LBP\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
LIPOPOLYSACCHARIDE-BINDING PROTEIN PRECURSOR (LBP). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.227244005\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.0691587\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0163276\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1623\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ARHGAP10\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.23959628\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.0681463\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0164226\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1922\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
PCYT1B\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
CHOLINEPHOSPHATE CYTIDYLYLTRANSFERASE B (EC 2.7.7.15) (PHOSPHORYLCHOLINE TRANSFERASE B) (CTP:PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE B) (CT B) (CCT B) (CCT-BETA). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.231969422\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.0707964\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0166846\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1733\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
SLC39A6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"LIV-1 PROTEIN, ESTROGEN REGULATED. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.23703891\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.0703876\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0167203\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2015\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
BCCIP\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
BRCA2 AND CDKN1A-INTERACTING PROTEIN ISOFORM BCCIPALPHA; BRCA2 AND CDKN1A-INTERACTING PROTEIN; CDK INHIBITOR P21 BINDING PROTEIN; BCCIPALPHA; BCCIPBETA; TOK-1ALPHA; TOK-1BETA. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230624509\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.0725001\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.016721\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2067\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
RAB26\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
RAS-RELATED PROTEIN RAB-26. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.229452092\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.0728736\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0167711\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1809\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
CPA5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
CARBOXYPEPTIDASE A5. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.234430345\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.0715398\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0174686\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3011\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
FCER2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
LOW AFFINITY IMMUNOGLOBULIN EPSILON FC RECEPTOR (LYMPHOCYTE IGE RECEPTOR) (FC-EPSILON-RII) (CD23) (BLAST-2) (IMMUNOGLOBULIN E-BINDING FACTOR). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.121834287\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.14338\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0174991\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1916\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
BIFUNCTIONAL 3'-PHOSPHOADENOSINE 5'-PHOSPHOSULFATE SYNTHETHASE 2 (PAPS SYNTHETHASE 2) (PAPSS 2) (SULFURYLASE KINASE 2) (SK2) (SK 2) [INCLUDES: SULFATE ADENYLYLTRANSFERASE (EC 2.7.7.4) (SULFATE ADENYLATE TRANSFERASE) (SAT) (ATP-SULFURYLASE); ADENYLYLSULFAT\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.231970338\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.0754368\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0175982\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1727\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
GAD2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"GLUTAMATE DECARBOXYLASE, 65 KDA ISOFORM (EC 4.1.1.15) (GAD-65) (65 KDA GLUTAMIC ACID DECARBOXYLASE). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.237039292\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.0742417\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0179282\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3195\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
STAMBP\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ASSOCIATED MOLECULE WITH THE SH3 DOMAIN OF STAM. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.036862223\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.486357\vspace{3pt}}\\\hline
\multirow{3}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
0.0184372\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
3175\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
NIPA2\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.055311655\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
0.333333\vspace{3pt}}}\\\cline{2-3}
&\parbox{\wcB}{\vspace{3pt}\noindent
3176\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
C6orf130\vspace{3pt}}&&&\\\cline{2-4}
&\parbox{\wcB}{\vspace{3pt}\noindent
3177\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
UBAC1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
PUTATIVE GLIALBLASTOMA CELL DIFFERENTIATION-RELATED; PUTATIVE GLIALBLASTOMA CELL DIFFERENTIATION-RELATED PROTEIN. \vspace{3pt}}&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0186658\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2632\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
CHRNA4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"NEURONAL ACETYLCHOLINE RECEPTOR PROTEIN, ALPHA-4 CHAIN PRECURSOR. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.209998965\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.0888852\vspace{3pt}}\\\hline
\multirow{3}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
0.018683\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
2933\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
RGS20\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
REGULATOR OF G-PROTEIN SIGNALING 20 (RGS20) (REGULATOR OF GZ- SELECTIVE PROTEIN SIGNALING 1) (GZ-SELECTIVE GTPASE-ACTIVATING PROTEIN) (G(Z)GAP). \vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.158415086\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
0.117937\vspace{3pt}}}\\\cline{2-4}
&\parbox{\wcB}{\vspace{3pt}\noindent
2934\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
RAP1GAP\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
RAP1 GTPASE-ACTIVATING PROTEIN 1 (RAP1GAP). \vspace{3pt}}&&\\\cline{2-4}
&\parbox{\wcB}{\vspace{3pt}\noindent
2935\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
RBM15B\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
CHROMOSOME 3P21.1 GENE SEQUENCE. \vspace{3pt}}&&\\\hline
\multirow{3}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
0.0187206\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
1917\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
POR\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
NADPH-CYTOCHROME P450 REDUCTASE (EC 1.6.2.4) (CPR) (P450R). \vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.231970222\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
0.0807026\vspace{3pt}}}\\\cline{2-4}
&\parbox{\wcB}{\vspace{3pt}\noindent
1918\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
PAPSS1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
BIFUNCTIONAL 3'-PHOSPHOADENOSINE 5'-PHOSPHOSULFATE SYNTHETHASE 1 (PAPS SYNTHETHASE 1) (PAPSS 1) (SULFURYLASE KINASE 1) (SK1) (SK 1) [INCLUDES: SULFATE ADENYLYLTRANSFERASE (EC 2.7.7.4) (SULFATE ADENYLATE TRANSFERASE) (SAT) (ATP-SULFURYLASE); ADENYLYLSULFAT\vspace{3pt}}&&\\\cline{2-4}
&\parbox{\wcB}{\vspace{3pt}\noindent
1919\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
PCYT1A\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
CHOLINEPHOSPHATE CYTIDYLYLTRANSFERASE A (EC 2.7.7.15) (PHOSPHORYLCHOLINE TRANSFERASE A) (CTP:PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE A) (CT A) (CCT A) (CCT-ALPHA). \vspace{3pt}}&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.018755\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2695\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
TBX6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
T-BOX TRANSCRIPTION FACTOR TBX6 (T-BOX PROTEIN 6). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.207986089\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.0901743\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0189378\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2633\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
STARD8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
STAR-RELATED LIPID TRANSFER PROTEIN 8 (STARD8) (START DOMAIN- CONTAINING PROTEIN 8). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.209998836\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.0901805\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0189917\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1950\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ESF1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.231320896\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.0821011\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0190828\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1992\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
HAS1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
HYALURONAN SYNTHASE 1 (EC 2.4.1.212) (HYALURONATE SYNTHASE 1) (HYALURONIC ACID SYNTHASE 1) (HA SYNTHASE 1) (HUHAS1). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.230850283\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.0826631\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0191226\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3040\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
PANK3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
PANTOTHENATE KINASE 3 (EC 2.7.1.33) (PANTOTHENIC ACID KINASE 3) (HPANK3). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.109787058\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.174179\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0193287\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2320\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
MASPIN PRECURSOR (PROTEASE INHIBITOR 5). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.2217965\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.0871461\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0193888\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3037\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
PANK2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"PANTOTHENATE KINASE 2, MITOCHONDRIAL PRECURSOR (EC 2.7.1.33) (PANTOTHENIC ACID KINASE 2) (HPANK2). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.109787489\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.176603\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0194204\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2326\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
SERPIN B11. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.221795594\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.0875599\vspace{3pt}}\\\hline
\multirow{3}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
0.0194686\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
1961\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
SCAPER\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ZINC FINGER PROTEIN 291. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.231218253\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.0842001\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
1963\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
MED11\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.231217978\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
0.0842002\vspace{3pt}}}\\\cline{2-4}
&\parbox{\wcB}{\vspace{3pt}\noindent
1964\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
PEX1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
PEROXISOME BIOGENESIS FACTOR 1 (PEROXIN-1) (PEROXISOME BIOGENESIS DISORDER PROTEIN 1). \vspace{3pt}}&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
0.0196287\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2712\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
TM7SF2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
DELTA(14)-STEROL REDUCTASE (EC 1.3.1.70) (C-14 STEROL REDUCTASE) (STEROL C14-REDUCTASE) (DELTA14-SR) (TRANSMEMBRANE 7 SUPERFAMILY MEMBER 2) (ANOTHER NEW GENE 1) (PUTATIVE STEROL REDUCTASE SR-1). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.207342721\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.0946679\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots
- http://analysis.yellowcouch.org/